Angola vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
Timor-Leste
1.0%
in 2024
Angola rank
5th
Timor-Leste rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- Timor-Leste
How they compare
Angola currently reports 3.1% against 1.0% in Timor-Leste, a difference of 2.1%.
That makes Angola's figure about 3.1 times Timor-Leste's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Timor-Leste ahead.
Angola ranks 5th and Timor-Leste ranks 3rd of 215 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 2.5% | 0.2% | Angola |
| 2020s | 3.0% | 1.3% | 1.7% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or Timor-Leste?
- Angola, at 3.1% against 1.0% in Timor-Leste as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and Timor-Leste?
- 2.1%, with Angola ahead.
- How many years of comparable data are there for Angola and Timor-Leste?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Timor-Leste rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and Timor-Leste ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.